Advance-Liver-Detox
Advanced Liver Detox

Why do we need Liver Detox?
The liver is a vital organ involved in the human digestive system. It performs over 500 varieties of functions, including metabolism, detoxification, protein synthesis, decomposition of red blood cells, hormone production and converting sugar into glycogen.  The liver is also responsible for processing many vitamins and nutrients into a form that can be utilized by the body. Heavy use of chemicals in modern living generates numerous toxic substances to our bodies, which imposes a heavy load on the liver. It is critical to your well being to protect the liver and maintain its function at optimal level.

Why do we choose to take Andorra International’s Advanced Liver Detox?
Andorra International’s Advanced Liver Detox contains 9 forms of natural and effective ingredients that help our bodies to regulate and maintain the healthy liver function.

Milk Thistle Extract:
Over the past forty years, intensive chemical, pharmacological and clinical research has confirmed the effectiveness of milk thistle in a wide range of human liver-related and non-liver-related conditions. Literally hundreds of modern research studies have confirmed the remarkable ability of milk thistle to protect the liver and the body against virtually all types of damage.

Additionally, the United States National Library of Medicine and the National Institutes of Health (NIH) have catalogued more than 400 scientific studies of milk thistle and its active compounds in their medicine database. These studies reflect what generations past knew and depended on – that milk thistle is one of the most valuable and beneficial herbal remedies and treatments available anywhere in the world.

The milk thistle extract is commonly used to treat mushroom poisoning, alcoholic cirrhosis, chronic hepatitis, drug and alcohol-induced liver damage and acute viral hepatitis, just to name a few.

Choline Bitartrate:
Choline is similar to the B vitamins. It can be made in the liver. It is also found in foods such as muscle meats, fish, nuts and beans. Choline is used to improve conditions of liver disease, such as chronic hepatitis and cirrhosis.

N-Acetyl L-Cysteine (NAC):
NAC is listed on the World Health Organization (WHO)’s list of essential medicines, as of the one most important medication needed in a basic health system. NAC is also commonly used for its antioxidant and liver protection effect.

Turmeric Extract (Curcumin):
In India and other parts of Asia, turmeric is used to treat many health conditions. It is believed to have anti-inflammatory and antioxidant properties. As a substance in Turmeric, Curcumin helps to reduce liver inflammation.

Proprietary Herb Blends:
Andorra’s Proprietary Herb Blends include Dandelion Root Extract, Artichoke Flower Extract, Schisandra Berry Extract, L-Methionine and Burdock Root Extract. These optimal blends of the best quality herbs help to maintain and keep your liver as well as gut’s healthy function.

Advanced Liver Detox Supplement Ingredients:
Liver Detox Supp Facts

References:

  1. Fu ZD, Csanaky IL, Klaassen CD. Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice. Drug Metab Dispos. 2012 Jun;40(6):1216-25.
  2. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C, Zilli M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J Hepatol. 1997 Apr;26(4):871-9.
  3. Yao J, Zhi M, Minhu C. Effect of silybin on high-fat-induced fatty liver in rats. Braz J Med Biol Res. 2011 Jul;44(7):652-9.
  4. Sangeetha N, Viswanathan P, Balasubramanian T, Nalini N. Colon cancer chemopreventive efficacy of silibinin through perturbation of xenobiotic metabolizing enzymes in experimental rats. Eur J Pharmacol. 2012 Jan 15;674(2-3):430-8.
  5. Pradhan SC, Girish C. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine. Indian J Med Res. 2006 Nov;124(5):491-504.
  6. Conti M, Malandrino S, Magistretti MJ. Protective activity of silipide on liver damage in rodents. Jpn J Pharmacol. 1992 Dec;60(4):315-21.
  7. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic.Biol Med. 2012;52(9):1658-65.
  8. Morazzoni P, Magistretti MJ, Giachetti C, Zanolo G. Comparative bioavailability of silipide, a new flavanolignan complex, in rats. Eur J Drug Metab Pharmacokinet. 1992 Jan-Mar;17(1):39-44.
  9. Morazzoni P, Montalbetti A, Malandrino S, Pifferi G. Comparative pharmacokinetics of silipide and silymarin in rats. Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):289-97.
  10. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 1990;15(4):333-38.
  11. Fan S, Yu Y, Qi M, et al. P53-mediated GSH depletion enhanced the cytotoxicity of NO in silibinin-treated human cervical carcinoma HeLa cells. Free Radic Res. 2012 Sep;46(9):1082-92.
  12. Abenavoli L, Capasso R, Milic N, Capasso F. Milk thistle in liver diseases: past, present, future.Phytother Res. 2010 Oct;24(10):1423-32.
  13. Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: A dose escalation study. Drug Metab Dispos. 2013 Jul 8. [Epub ahead of print]
  14. Ramasamy K, Agarwal R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008 Oct 8;269(2):352-62.
  15. Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice. Clin Cancer Res. 2010 Sep 15;16(18):4595-606.
  16. Song Z, Deaciuc I, Song M, et al. Silymarin protects against acute ethanol-induced hepatotoxicity in mice. Alcohol Clin Exp Res. 2006 Mar;30(3):407-13.
  17. Kidd P Fau – Head K, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev. 2005 Sep;10(3):193-203.
  18. Dolphin D. Cytochrome P450: substrate and prosthetic-group free radicals generated during the enzymatic cycle. Philos Trans R Soc Lond B Biol Sci. 1985 Dec 17;311(1152):579-91.
  19. Flora K, Hahn M, Rosen H, Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 1998 Feb;93(2):139-43.
  20. Kren V, Walterova D. Silybin and silymarin–new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):29-41.
  21. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev. 2009;14(3):226-46.
  22. Dixit N, Baboota S, Kohli K, Ahmad S, Ali J. Silymarin: A review of pharmacological aspects and bioavailability enhancement approaches. Indian J Pharmacol. 2007;39(4):172-79.
  23. Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis. Transl Res. 2012 Jun;159(6):477-86.
  24. Loguercio C, Andreone P, Brisc C, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med. 2012 May 1;52(9):1658-65.
  25. Kim M, Yang SG, Kim JM, Lee JW, Kim YS, Lee JI. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. Int J Mol Med. 2012 Sep;30(3):473-9.
  26. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology. 2008 Jun;47(6):1947-54.
  27. Stravitz RT, Sanyal AJ, Reisch J, Bajaj JS, Mirshahi F, Cheng J, Lee WM; Acute LiverFailure Study Group. Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int. 2013 Oct;33(9):1324-31. doi: 10.1111/liv.12214. Epub 2013 Jun 19.
  28. Tian YM, Dou LP, Yao S, Yao ZL, Zhang QF, Yu L, Jing Y. [Protective effect of ademetionine 1, 4-butanedisulfonate on liver injury caused by chemotherapeutic agents]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1305-8. doi: 10.7534/j.issn.1009-2137.2013.05.044. Chinese.
  29. Grela ER, Sobolewska S, Roziński T. Effect of inulin extracts or inulin-containing plant supplement on blood lipid indices and fatty acid profile in fattener tissues. Pol J Vet Sci. 2014;17(1):93-8.
  30. Chiu HF, Chen TY, Tzeng YT, Wang CK. Improvement of liver function in humans using a mixture of schisandra fruit extract and sesamin. Phytother Res. 2013 Mar;27(3):368-73. doi: 10.1002/ptr.4702. Epub 2012 May 21.
  31. Stel makh VV, Kozlov VK.  [Metabolic correction of dyslipidemia in patients with nonalcoholic fatty liver disease as a new therapy policy]. Ter Arkh. 2013;85(4):71-6. Russian.
  32. Lin CC, Lu JM, Yang JJ, Chuang SC, Ujiie T. Anti-inflammatory and radical scavenge effects of Arctium lappa. Am J Chin Med. 1996;24(2):127-37.